1Carlson CS,Huilak F,Vail TP,et al.Synovial fluid biomarker levels predict articular cartilage damage following complete me-dial meniscectomy in the canine knee.J Orthop Res,2002,20(1):92-100.
2Riessen R,Fenchel M,Chen H,et al.Cartilage oligometic matrix proteins(thrombospindin-5)is expressed by human vascular smooth muscle cells.Arterioscler Thromb Vasc Bio,2001,21(1):47-54.
3Fife RS,Brandt KD.Identification of a high-molecular weight(4000,000)protein in hyaline cartilage.Biochim Biophys Acta,1994,802:506-514.
4Heinegard D,Oldberg A,Antonsson P,et al.COMP(cartilage oligomeric matrix protein)is structurally related to the throm-bospondins.J Biol Chem,1992,267:22346-22350.
5Larsson E,Harris H,Erlandsson,et al.Serum concentrations of cartilage oligomeric matrix protein,fibrinogen and hyaluron dis-tinguish inflammation and cartilage destruction in experimental arthritis in rats,2002,41(9):996-1000.
6Fang C,di Cesarep E,Leslie MP,et al.Localiation and expres-sion of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage.J Orthop Res,1999,17(3):437-445.
7Dai SM,Shan ZZ,Nishioka K,et al.Implication of interleukin18in production of matrix metalloproteinases in articular chondro-cytes in arthritis:direct effect on chondroeytes may not be pivo-tal.Ann Rheum Dis,2005,64(5):735-742.
8Lindqvist E,Eberhardt K,Bendtzen K,et al.Prognostic laborato-ry makers of jiont damage in rheumatoid arthritis.Ann Rheum Dis,2005,64:196-201.
同被引文献44
1Fife RS, Brandt KD. Cartilage matrix glycoprotein is present in serum in experimental canine osteoarthritis [J]. J Clin Invest, 1989,84(5): 1432-1439.
2Aleom JL, Merritt TM, Farach-Carson MC, et al. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomerie matrix protein (COMP)mRNA and protein[J]. RNA, 2009,15(4):686-695.
3Rock MJ, Holden P, Horton WA, et al. Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms in- volving CD47 and alphaVbeta3 integrin [J]. Mol Cell Bioehem, 2010,338(1-2) :215-224.
4Bender AL, Da Silveira IG, Von Muhlen CA, et al. High specificity but low sensitivity of the cartilage oligomeric matrix protein(COMP) test in rheumatoid arthritis and osteoarthritis [J]. Clin Chom Lab Med, 2010,48(45): 69-570.
5Tseng S, Reddi AH, Di Cesare PE. Cartilage Oligomeric Matrix Pro- tein(COMP):A Biomarker of Arthritis[J]. Biomark Insights, 2009,17 (4):33-44.
6Toehigi Y, Buckwalter JA, Martin JA, et al. Distribution and progres- sion of chondrocyte damage in a whole-organ model of human ankle intra-articular fracture[J]. J Bone JointSurg Am, 2011,93(6):533-539.
7Helmark IC, Petersen MC, Christensen HE, et al. Moderate loading of the human osteoarthritic knee joint leads to lowering of intraarticular cartilage oligomeric matrix protein [J]. Rheumatology, 2012,32(4): 1009-1014.
8Gagarina V, Carlberg AL, Pereira-Mouries L, et al. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins [J]. J Biol Chem, 2008,283(1):648-659.
9Posey KL, Hecht JT. The role of cartilage oligomeric matrix protein (COMP)in skeletal disease[J]. Curr Drug Targets, 2008,9(10):869-877.
10Rock MJ, Holden P, Horton WA, et al. Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms in- volving CD47 and alphaVbeta3 integrin [J]. Mol Cell Biochem, 2010,338(1-2):215-224.
